Paper39225830
Metformin and the PI3K/AKT signaling pathway: implications for cancer, cardiovascular, and central nervous system diseases.
Ashayeri Ahmadabad H and 5 others. Naunyn Schmiedebergs Arch Pharmacol, 2025. Cited by 19 papers, by iCite.
Cite this record
ConductScience Library. Metformin and the PI3K/AKT signaling pathway: implications for cancer, cardiovascular, and central nervous system diseases. Papers, record 39225830. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39225830
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Metformin and the PI3K/AKT signaling pathway: implications for cancer, cardiovascular, and central nervous system diseases.
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Metformin | Major topic |
| Proto-Oncogene Proteins c-akt | Major topic |
| Neoplasms | Major topic |
| Cardiovascular Diseases | Major topic |
| Phosphatidylinositol 3-Kinases | Major topic |
| Central Nervous System Diseases | Major topic |
| Hypoglycemic Agents | Major topic |
| Humans | |
| Signal Transduction | |
| Animals |
Source PubMed
References142
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 17054901 | Dynamic phospholipid signaling by G protein-coupled receptors. | Biochim Biophys Acta | 2007 | https://conductscience.org/library/papers/17054901 | PubMed |
| 2 | 31611073 | Class I phosphoinositide 3-kinase (PI3K) regulatory subunits and their roles in signaling and disease. | Adv Biol Regul | 2020 | https://conductscience.org/library/papers/31611073 | PubMed |
| 3 | 35118422 | The present and future of PI3K inhibitors for cancer therapy. | Nat Cancer | 2021 | https://conductscience.org/library/papers/35118422 | PubMed |
| 4 | 10329640 | Insulin activates the alpha isoform of class II phosphoinositide 3-kinase. | J Biol Chem | 1999 | https://conductscience.org/library/papers/10329640 | PubMed |
| 5 | 19143635 | A complex interplay between Akt, TSC2 and the two mTOR complexes. | Biochem Soc Trans | 2009 | https://conductscience.org/library/papers/19143635 | PubMed |
| 6 | 30849534 | The relation between PI3K/AKT signalling pathway and cancer. | Gene | 2019 | https://conductscience.org/library/papers/30849534 | PubMed |
| 7 | 31161345 | Type 2 diabetes: a multifaceted disease. | Diabetologia | 2019 | https://conductscience.org/library/papers/31161345 | PubMed |
| 8 | 28527533 | Global, Regional, and National Burden of Cardiovascular Diseases for 10 Causes, 1990 to 2015. | J Am Coll Cardiol | 2017 | https://conductscience.org/library/papers/28527533 | PubMed |
| 9 | 21277873 | Peripheral insulin-sensitizer drug metformin ameliorates neuronal insulin resistance and Alzheimer's-like changes. | Neuropharmacology | 2011 | https://conductscience.org/library/papers/21277873 | PubMed |
| 10 | 24519956 | Targeting Src-mediated Tyr216 phosphorylation and activation of GSK-3 in prostate cancer cells inhibit prostate cancer progression in vitro and in vivo. | Oncotarget | 2014 | https://conductscience.org/library/papers/24519956 | PubMed |
| 11 | 9609111 | Insulin regulation of the Ras activation/inactivation cycle. | Mol Cell Biochem | 1998 | https://conductscience.org/library/papers/9609111 | PubMed |
| 12 | 19622833 | Inhibition of mTOR signaling in Parkinson's disease prevents L-DOPA-induced dyskinesia. | Sci Signal | 2009 | https://conductscience.org/library/papers/19622833 | PubMed |
| 13 | 34298660 | Akt Isoforms: A Family Affair in Breast Cancer. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/34298660 | PubMed |
| 14 | 31275108 | Altered Insulin Signaling in Alzheimer's Disease Brain - Special Emphasis on PI3K-Akt Pathway. | Front Neurosci | 2019 | https://conductscience.org/library/papers/31275108 | PubMed |
| 15 | 32792857 | Metformin suppresses inflammation and apoptosis of myocardiocytes by inhibiting autophagy in a model of ischemia-reperfusion injury. | Int J Biol Sci | 2020 | https://conductscience.org/library/papers/32792857 | PubMed |
| 16 | 29678660 | Metformin combined with quercetin synergistically repressed prostate cancer cells via inhibition of VEGF/PI3K/Akt signaling pathway. | Gene | 2018 | https://conductscience.org/library/papers/29678660 | PubMed |
| 17 | 33450488 | Curcumin and cardiovascular diseases: Focus on cellular targets and cascades. | Biomed Pharmacother | 2021 | https://conductscience.org/library/papers/33450488 | PubMed |
| 18 | 34283253 | Metformin prevents p-tau and amyloid plaque deposition and memory impairment in diabetic mice. | Exp Brain Res | 2021 | https://conductscience.org/library/papers/34283253 | PubMed |
| 19 | 20563706 | Role of RAS in the regulation of PI 3-kinase. | Curr Top Microbiol Immunol | 2010 | https://conductscience.org/library/papers/20563706 | PubMed |
| 20 | 31170502 | The beneficial roles of metformin on the brain with cerebral ischaemia/reperfusion injury. | Pharmacol Res | 2019 | https://conductscience.org/library/papers/31170502 | PubMed |
Cited by15
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 19 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42904151 | Molecular Mechanisms and Signaling Pathways Underlying the Synergistic Effect of Metformin and Paclitaxel in Preclinical Cancer Models: A Systematic Review. | Cancer Manag Res | 2026 | https://conductscience.org/library/papers/42904151 | PubMed |
| 42737460 | Functional Characterization of Putative Novel MicroRNA-1133 in the Antioxidant Effects of Metformin in Hyperglycemia-Induced Endothelial Cells. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42737460 | PubMed |
| 42656432 | Exploring the relationship between uric acid-to-HDL cholesterol ratio and vascular calcification: evidence from clinical, genetic, and network-based analyses. | Front Cardiovasc Med | 2026 | https://conductscience.org/library/papers/42656432 | PubMed |
| 42439660 | Deciphering the Anti-Tumor Mechanisms of Metformin Through Reprogramming of the Tumor Microenvironment. | Cells | 2026 | https://conductscience.org/library/papers/42439660 | PubMed |
| 42136854 | Mechanisms of interaction between type 2 diabetes and psychological disorders and therapeutic interventions: a narrative review. | Front Med (Lausanne) | 2026 | https://conductscience.org/library/papers/42136854 | PubMed |
| 41704279 | Repurposing metformin for cardioprotection: mechanisms and therapeutic potential across cardiovascular pathologies. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/41704279 | PubMed |
| 41562920 | Integrative Sequencing and Proteogenomic Approaches to Intratumoral Heterogeneity in Cholangiocarcinoma: Implications for Precision Diagnosis and Therapy. | Med Sci (Basel) | 2026 | https://conductscience.org/library/papers/41562920 | PubMed |
| 41382186 | Enhancing PARP inhibitor efficacy in ovarian cancer: targeting the PI3K/AKT/mTOR pathway. | J Ovarian Res | 2025 | https://conductscience.org/library/papers/41382186 | PubMed |
| 41373567 | Antitumor Activity of Metformin in Combination with Binimetinib Against Melanoma Cells. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41373567 | PubMed |
| 41366593 | Therapeutic Efficacy of Autologous Blood-Derived Stem Cells with Growth Factors in Moderate to Severe Alzheimer's Disease: A Clinical Trial. | Mol Neurobiol | 2025 | https://conductscience.org/library/papers/41366593 | PubMed |
| 41185504 | Aloperine Protects Against Cisplatin-Induced Injury in Kidney Cells Via Modulating PI3K/AKT/Nfκb-Mediated NLRP3 Inflammasome. | Protein Pept Lett | 2025 | https://conductscience.org/library/papers/41185504 | PubMed |
| 41082699 | Hesperidin and Hesperetin from Orange Peel Water Extract Protect against NaIO3-Induced Oxidative Damage in Retinal Pigment Epithelial Cells by Modulating PI3K/Akt/HIF-1α/BNIP3 Signaling. | J Agric Food Chem | 2025 | https://conductscience.org/library/papers/41082699 | PubMed |
| 40916522 | [Exosome-derived miR-1275 mediates IL-38 upregulation in lymphocytes to suppress lipopolysaccharide-induced apoptosis of myocardial cells in vitro]. | Nan Fang Yi Ke Da Xue Xue Bao | 2025 | https://conductscience.org/library/papers/40916522 | PubMed |
| 40805165 | Metformin Beyond Diabetes: A Precision Gerotherapeutic and Immunometabolic Adjuvant for Aging and Cancer. | Cancers (Basel) | 2025 | https://conductscience.org/library/papers/40805165 | PubMed |
| 40385486 | Randomized, double-blind, placebo-controlled pilot study of metformin as an adjunctive therapy in Parkinson's disease. | Front Pharmacol | 2025 | https://conductscience.org/library/papers/40385486 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| AKT1 | 207 | PubTator's text mining | https://conductscience.org/library/genes/207 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39225830
GET https://conductscience.org/api/papers/v1/39225830/references?page=2